Literature DB >> 11809169

Cerebral grey matter pathology and fatigue in patients with multiple sclerosis: a preliminary study.

M Codella1, M A Rocca, B Colombo, F Martinelli-Boneschi, G Comi, M Filippi.   

Abstract

In patients with multiple sclerosis (MS), we investigated whether the extent of cerebral grey matter (GM) pathology is associated with the presence and severity of fatigue. We quantified cerebral GM pathology in 28 MS patients (14 with fatigue and 14 without fatigue) using magnetization transfer (MT) and diffusion tensor (DT) magnetic resonance imaging (MRI). The average MT ratio and mean diffusivity from cerebral GM did not differ between fatigued and non-fatigued patients. Fatigued and non-fatigued patients also did not differ in terms of GM pathology of the cerebral cortex of the frontal lobe and basal ganglia. No correlations were found between the fatigue severity scale scores and any of the MT- and DT-MRI quantities. These preliminary results suggest that structural GM pathology is not a major contributing factor to the development of fatigue in patients with MS.

Entities:  

Mesh:

Year:  2002        PMID: 11809169     DOI: 10.1016/s0022-510x(01)00682-7

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  14 in total

Review 1.  MRI evidence for multiple sclerosis as a diffuse disease of the central nervous system.

Authors:  Massimo Filippi; Maria Assunta Rocca
Journal:  J Neurol       Date:  2005-11       Impact factor: 4.849

2.  Functional and structural balances of homologous sensorimotor regions in multiple sclerosis fatigue.

Authors:  I Cogliati Dezza; G Zito; L Tomasevic; M M Filippi; A Ghazaryan; C Porcaro; R Squitti; M Ventriglia; D Lupoi; F Tecchio
Journal:  J Neurol       Date:  2014-12-19       Impact factor: 4.849

3.  Is central fatigue in multiple sclerosis a disorder of movement preparation?

Authors:  Francesca Morgante; Vincenzo Dattola; Domenica Crupi; Margherita Russo; Vincenzo Rizzo; Maria Felice Ghilardi; Carmen Terranova; Paolo Girlanda; Angelo Quartarone
Journal:  J Neurol       Date:  2010-09-22       Impact factor: 4.849

4.  Fatigue and progression of corpus callosum atrophy in multiple sclerosis.

Authors:  Özgür Yaldizli; Stephanie Glassl; Dietrich Sturm; Athina Papadopoulou; Achim Gass; Barbara Tettenborn; Norman Putzki
Journal:  J Neurol       Date:  2011-05-19       Impact factor: 4.849

5.  The basal ganglia: a substrate for fatigue in multiple sclerosis.

Authors:  N Téllez; J Alonso; J Río; M Tintoré; C Nos; X Montalban; A Rovira
Journal:  Neuroradiology       Date:  2007-10-23       Impact factor: 2.804

6.  Quality of life in multiple sclerosis is associated with lesion burden and brain volume measures.

Authors:  E M Mowry; A Beheshtian; E Waubant; D S Goodin; B A Cree; P Qualley; R Lincoln; M F George; R Gomez; S L Hauser; D T Okuda; D Pelletier
Journal:  Neurology       Date:  2009-05-19       Impact factor: 9.910

Review 7.  Magnetization transfer magnetic resonance imaging of the brain, spinal cord, and optic nerve.

Authors:  Massimo Filippi; Maria A Rocca
Journal:  Neurotherapeutics       Date:  2007-07       Impact factor: 7.620

8.  Dilated perivascular spaces and fatigue: is there a link? Magnetic resonance retrospective 3Tesla study.

Authors:  Renata Conforti; Mario Cirillo; Angela Sardaro; Giuseppina Caiazzo; Alberto Negro; Antonella Paccone; Rosaria Sacco; Maddalena Sparaco; Antonio Gallo; Luigi Lavorgna; Gioacchino Tedeschi; Sossio Cirillo
Journal:  Neuroradiology       Date:  2016-07-16       Impact factor: 2.804

9.  Clinically feasible MTR is sensitive to cortical demyelination in MS.

Authors:  Jacqueline Tien-Hsiang Chen; Kathryn Easley; Colleen Schneider; Kunio Nakamura; Grahame J Kidd; Ansi Chang; Susan M Staugaitis; Robert J Fox; Elizabeth Fisher; Douglas L Arnold; Bruce D Trapp
Journal:  Neurology       Date:  2012-12-26       Impact factor: 9.910

10.  Deep gray matter and fatigue in MS: a T1 relaxation time study.

Authors:  G Niepel; Ch R Tench; P S Morgan; N Evangelou; D P Auer; C S Constantinescu
Journal:  J Neurol       Date:  2006-03-13       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.